Cure8

Why This Matters

The report suggests Kono‑S is safe and feasible with shorter hospital stays and fewer ileostomies in this early-adoption cohort, which could matter to patients and surgeons planning ileocecal resection.

However, early recurrence appears driven more by postoperative biologic use than by anastomotic technique in this series.

Who Should Pay Attention

Adults with Crohn's disease undergoing ileocecal resection; post‑surgery patients and caregivers; colorectal surgeons; researchers studying surgical recurrence prevention.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This analysis focuses on short-term perioperative safety and feasibility during early adoption (2020–2025). Compared with conventional techniques, the Kono‑S technique in this cohort was associated with a shorter median length of stay (5.1 vs 7.3 days) and a lower rate of defunctioning ileostomy (8.8% vs 44.4%).

There were no anastomotic leaks or major (Clavien‑Dindo ≥ III) complications reported in the Kono‑S group. The study did not find a statistically significant reduction in 12‑month endoscopic recurrence attributable to the Kono‑S technique; postoperative biologic therapy was the only factor associated with lower recurrence in multivariable analysis.

As a retrospective, early‑adoption series, results emphasize perioperative safety and feasibility rather than long‑term recurrence benefits.

Keep In Mind

Retrospective design, early‑adoption timeframe, and abstract/preprint status mean results are preliminary. The study emphasizes perioperative safety and feasibility; larger prospective or randomized studies with longer follow‑up are needed to assess recurrence effects.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationEurope PMC
AuthorsSeow W, Ong K, Barnes A +5 more
Study typePreprint
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 31, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →